Back to Search Start Over

DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.

Authors :
Sun, Xin
Tang, Shou ‐ Ching
Xu, Chongwen
Wang, Chenguang
Qin, Sida
Du, Ning
Liu, Jian
Zhang, Yiwen
Li, Xiang
Luo, Gang
Zhou, Jie
Xu, Fei
Ren, Hong
Source :
Journal of Cellular & Molecular Medicine; Jun2015, Vol. 19 Issue 6, p1357-1365, 9p
Publication Year :
2015

Abstract

Let-7 mi RNAs act as tumour suppressors by directly binding to the 3′ UTRs of downstream gene products. The regulatory role of let-7 in downstream gene expression has gained much interest in the cancer research community, as it controls multiple biological functions and determines cell fates. For example, one target of the let-7 family is cyclin D1, which promotes G0/S cell cycle progression and oncogenesis, was correlated with endoribonuclease DICER1, another target of let-7. Down-regulated let-7 has been identified in many types of tumours, suggesting a feedback loop may exist between let-7 and cyclin D1. A potential player in the proposed feedback relationship is Dicer, a central regulator of mi RNA expression through sequence-specific silencing. We first identified that DICER1 is the key downstream gene for cyclin D1-induced let-7 expression. In addition, we found that let-7 miRNAs expression decreased because of the p53-induced cell death response, with deregulated cyclin D1. Our results also showed that cyclin D1 is required for Nutlin-3 and TAX-induced let-7 expression in cancer repression and the cell death response. For the first time, we provide evidence that let-7 and cyclin D1 form a feedback loop in regulating therapy response of cancer cells and cancer stem cells, and importantly, that alteration of let-7 expression, mainly caused by cyclin D1, is a sensitive indicator for better chemotherapies response. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15821838
Volume :
19
Issue :
6
Database :
Complementary Index
Journal :
Journal of Cellular & Molecular Medicine
Publication Type :
Academic Journal
Accession number :
102915358
Full Text :
https://doi.org/10.1111/jcmm.12522